Received Aug 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
As the IM vaccine was being administered, I felt a pain at the injection site and up into my neck; pain at the injection site and up into my neck; This non-serious case was reported by a consumer and described the occurrence of injection site pain in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included hypothyroidism, blood cholesterol increased and rheumatoid arthritis. Concomitant products included methotrexate, rosuvastatin and levothyroxine. On 30-JUL-2025, the patient received Shingrix. On 30-JUL-2025, less than a day after receiving Shingrix, the patient experienced injection site pain (Verbatim: As the IM vaccine was being administered, I felt a pain at the injection site and up into my neck) and neck pain (with radiation) (Verbatim: pain at the injection site and up into my neck). The outcome of the injection site pain and neck pain (with radiation) were not resolved. It was unknown if the reporter considered the injection site pain and neck pain (with radiation) to be related to Shingrix. It was unknown if the company considered the injection site pain and neck pain (with radiation) to be related to Shingrix. Additional Information: GSK Receipt Date: 31-JUL-2025 Consumer was reported as the IM vaccine was being administered and felt a pain at the injection site and up into neck. The reporter also mentioned that receive weekly P.T. on my neck for disc calcification, and do not had nerve damage on the left side of my neck where the injection pain was felt. The end date was provided as 30-JUL-2025.
Blood cholesterol increased; Hypothyroidism; Rheumatoid arthritis
METHOTREXATE; ROSUVASTATIN; LEVOTHYROXINE